American Healthcare REIT Announces Third Quarter 2026 Results

American Healthcare REIT, Inc. (AHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 r Press Release Irvine, CA – November 5, 2026 Contact: Alan Peterson Email: investorrelations@ahcreit.com American Healthcare REIT Announces Third Quarter 2026 Results; Increases Full Year 2026 Guidance American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,”

Original reporting
Published Nov 5, 2026, 9:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AHR
Bullish
high confidence
Mentioned
$AHR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AHRBullishHigh
01

Why it matters

The raised guidance and strong same‑store NOI growth signal robust operational performance, likely supporting a rally in AHR.

02

Market read

AHR's earnings beat and guidance lift provide fresh, material information for traders, making the stock a near‑term buy candidate.

03

What to watch

Potential execution risk on the $1.32B of unsettled forward sale agreements could temper upside.

Relevance 7/10Novelty 8/10Timing: today

Background

American Healthcare REIT filed an 8‑K reporting Q3 results, portfolio growth, and increased full‑year guidance.

Company-level read

Ticker impact

$AHRBullishHigh confidence
Context

Company announced Q3 2026 results and increased full-year guidance, including higher NFFO per share and portfolio NOI growth.

Expected impact

upward pressure as investors price in higher NFFO and NOI growth guidance

Evidence & confidence

The earnings release includes new, material guidance upgrades and a sizable $1.69B acquisition, which are fresh primary disclosures for a mid‑cap REIT.

Market effects

Higher REIT earnings may lift other senior‑housing and healthcare real estate stocks.

Positive for U.S. REIT sector and broader equity markets.

Limited to U.S. REIT investors but may influence global real‑estate funds tracking U.S. exposure.

Counterpoint

If the market has already priced in the guidance lift, the stock could face short‑term profit‑taking.

Key entities

  • American Healthcare REIT, Inc.

    NYSE‑listed REIT focused on senior housing and integrated health campuses.

  • Jeff Hanson

    Chairman and newly appointed CEO of AHR.

Related articles

$AHRMedAI 8/10

American Healthcare REIT Q3 Earnings Call Highlights

American Healthcare REIT (AHR) reported Q3 gains in senior housing occupancy and margins. SHOP same-store NOI rose 28.2% YoY, with occupancy at 90%. Trilogy's NOI grew 15.7% YoY, occupancy at 91.2%. The company invested $2.1B YTD, including six Kensington communities for $572M. AHR's net debt to EBITDA is 1.9x, with $1.3B in funding available. The company plans to focus on SHOP and Trilogy for future growth, selling non-core assets.

$AHRHighAI 8/10

Truist reiterates Buy on American Healthcare REIT stock after earnings

Truist reiterated a Buy rating and $61 price target on American Healthcare REIT (AHR) after its earnings beat estimates, driven by senior housing revenue growth and lower expenses. The stock is up 20.88% YTD, but some analysts consider it overvalued. KeyBanc raised its target to $68, while Citizens maintained a Market Outperform rating with a $65 target. Raymond James initiated coverage with a Strong Buy, citing strong acquisition activity and partnerships.

$AHRHighAI 8/10

American Healthcare REIT: Q3 Earnings Snapshot

American Healthcare REIT (AHR) reported Q3 funds from operations of $126.6M, or 58 cents per share, beating estimates of 56 cents. Revenue was $742.1M. The company expects full-year FFO between $2.23 and $2.26 per share. Shares have risen 19% year-to-date and 19% over the past year, closing at $56.10.